GENO Analyst Estimates: Price Targets, Revenue, Net Income, and EBIT Forecast - Genovis AB - Alpha Spread
G

Genovis AB
STO:GENO

Watchlist Manager
Genovis AB
STO:GENO
Watchlist
Price: 23.45 SEK 0.43% Market Closed
Market Cap: 1.5B SEK
Have any thoughts about
Genovis AB?
Write Note

Wall Street
Price Targets

GENO Price Targets Summary
Genovis AB

Wall Street analysts forecast GENO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GENO is 43.86 SEK with a low forecast of 34.34 SEK and a high forecast of 54.6 SEK.

Lowest
Price Target
34.34 SEK
46% Upside
Average
Price Target
43.86 SEK
87% Upside
Highest
Price Target
54.6 SEK
133% Upside
Genovis AB Competitors:
Price Targets
688222
HitGen Inc
87% Upside
300030
Improve Medical Instruments Co Ltd
232% Upside
NEO
Neogenomics Inc
32% Upside
TMO
Thermo Fisher Scientific Inc
5% Upside
ALIF B
AddLife AB
6% Upside
IQV
IQVIA Holdings Inc
15% Upside
LAB
Standard BioTools Inc
66% Upside
ORPH
Open Orphan PLC
199% Upside

Revenue
Forecast

Revenue Estimate
Genovis AB

For the last 8 years the compound annual growth rate for Genovis AB's revenue is 36%. The projected CAGR for the next 3 years is 13%.

36%
Past Growth
13%
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Genovis AB

The compound annual growth rate of Genovis AB's operating income for the next 3 years is 16%.

N/A
Past Growth
16%
Estimated Growth
Estimates Accuracy
-18%
Average Miss

Net Income
Forecast

Net Income Estimate
Genovis AB

The compound annual growth rate of Genovis AB's net income for the next 3 years is 1%.

N/A
Past Growth
1%
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GENO's stock price target?
Price Target
43.86 SEK

According to Wall Street analysts, the average 1-year price target for GENO is 43.86 SEK with a low forecast of 34.34 SEK and a high forecast of 54.6 SEK.

What is Genovis AB's Revenue forecast?
Projected CAGR
13%

For the last 8 years the compound annual growth rate for Genovis AB's revenue is 36%. The projected CAGR for the next 3 years is 13%.

What is Genovis AB's Operating Income forecast?
Projected CAGR
16%

The compound annual growth rate of Genovis AB's operating income for the next 3 years is 16%.

What is Genovis AB's Net Income forecast?
Projected CAGR
1%

The compound annual growth rate of Genovis AB's net income for the next 3 years is 1%.

Back to Top